Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications. The heart is a key target as well as a source of FGF21 which is involved in he...
Saved in:
| Main Authors: | Peng Cheng, Fangfang Zhang, Lechu Yu, Xiufei Lin, Luqing He, Xiaokun Li, Xuemian Lu, Xiaoqing Yan, Yi Tan, Chi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2016/1540267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on the role of FGF21 in insulin resistance
by: Haixin Zhang, et al.
Published: (2025-08-01) -
FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice
by: Ke Zhang, et al.
Published: (2025-02-01) -
A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)
by: Zhipeng Zhang, et al.
Published: (2025-04-01) -
Molecular characterization and mapping of Fgf21 gene in a foodfish species asian seabass.
by: Le Wang, et al.
Published: (2014-01-01) -
FGF21 gene therapy as treatment for obesity and insulin resistance
by: Veronica Jimenez, et al.
Published: (2018-07-01)